Nation
World
Politics
Sports
Business
Entertainment
Life
Tech
Science
Opinion
Crime
Health
Oddities

Genmab: EMA To Review MAA Of Tisotumab Vedotin

Por: RTTNews Health February 02, 2024

thumbnail

Genmab A/S () and Pfizer, Inc. () announced the European Medicines Agency has validated for review the marketing authorization application of tisotumab vedotin, an antibody-drug conjugate, developed for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after systemic therapy. The MAA is based on data from the global, randomized, Phase 3 innovaTV 301 trial. Tisotumab vedotin is an... + full article



Similar News

Valneva Reports EMA's MAA Review Acceptance For Chikungunya Vaccine Candidate VLA1553

RTTNews USA Health November 27, 2023

thumbnailValneva SE () announced that the European Medicines Agency has performed a technical validation of the Marketing Authorization Application for the company's single-shot chikungunya vaccine candidate VLA1553 and has determined that all essential regulatory elements required... + más

Valneva Reports Positive Safety Data In Adolescents For Chikungunya Vaccine Candidate | RTTNews

The Luxurious Kimpton Maa-Lai Bangkok Hotel Celebrates The Holidays | Forbes


Krystal Biotech Says EMA Validated MAA For VYJUVEK For Dystrophic Epidermolysis Bullosa

RTTNews USA Health November 27, 2023

thumbnailBiotechnology company Krystal Biotech, Inc. () announced Monday that the Company's Marketing Authorization Application (MAA) to the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) for VYJUVEK (beremagene geperpavec-svdt or B-VEC)... + más

Why Is Krystal Shining? | RTTNews

High school scores and top performers from Friday, March 24 | Orlando Sentinel


Merck Says Phase 3 KEYNOTE-A39/EV-302 Trial Meets Dual Primary Endpoints

RTTNews USA Health September 22, 2023

thumbnailMerck & Co Inc. (), known as MSD outside of the U.S. and Canada, announced Friday positive topline results from the Phase 3 KEYNOTE-A39 trial, which was conducted in collaboration with Seagen Inc. () and Astellas Pharma Inc. (ALPMY.PK,).The trial evaluated KEYTRUDA, Merck's... + más

Column: Merck says it's being 'coerced' into negotiating its drug prices with Medicare. That's nonsense | Los Angeles Times

Merck sues U.S., calling Biden move to cut drug prices ‘extortion’ | Portland Press Herald


Extremely revealing ‘Vagina G-string’ bikini explodes at Miami Swim Week 2023

New York Post USA Life July 07, 2023

thumbnailWe’re no stranger to skimpy swimwear trends following the in recent years. But an eye-popping new take on the popular swimsuit has emerged at day one of that is so skimpy, it is arguably indecent. Swimwear designers have been slowly adopting “minimalism” in their... + más

Vagina Museum Closes In London | Forbes

'Baywatch' alum Donna D'Errico fires back after her bikini post on social media was labeled 'raunchy' | Fox News


The Luxurious Kimpton Maa-Lai Bangkok Hotel Celebrates The Holidays

Forbes USA Life December 16, 2022

thumbnailAt Kimpton Maa-Lai Bangkok, the five-star boutique hotel pulls out all the stops to celebrate the ... [+] most wonderful time of the year. Kimpton Maa-Lai Bangkok At , the five-star boutique hotel pulls out all the stops to celebrate the most wonderful time of the year with a... + más

Why A U.S. Member Of Congress Should Adopt Jimmy Lai | Forbes

Hong Kong pro-democracy publisher may face life in prison under security law | Los Angeles Times


AbbVie Says EMA Validates MAA For Epcoritamab To Treat Relapsed/refractory Diffuse Large B-cell

RTTNews USA Health October 28, 2022

thumbnailAbbVie () announced Friday that the European Medicines Agency (EMA) has validated a Marketing Authorization Application (MAA) for epcoritamab (DuoBody-CD3xCD20), an investigational subcutaneous bispecific antibody, for the treatment of adult patients with relapsed/refractory... + más

Don’t Pay for Cord-Blood Banking | The Atlantic

Prime Video’s Aparna Purohit Reveals How Madhuri Dixit Got Onboard For ‘Maja Ma’ | Forbes


Prime Video’s Aparna Purohit Reveals How Madhuri Dixit Got Onboard For ‘Maja Ma’

Forbes USA Business October 09, 2022

thumbnailBollywood actress Madhuri Dixit poses for pictures during the promotion of the Amazon Prime Video ... [+] first original Indian Hindi-language film 'Maja Maa' in Mumbai Mumbai on September 22, 2022. (Photo by SUJIT JAISWAL / AFP) (Photo by SUJIT JAISWAL/AFP via Getty... + más

Madhuri Vijay on Cruelty as Righteousness | The Atlantic

This Baltimore Restaurateur Promotes Rare Ingredients From The Amazon In Her Bar Program | Forbes



About iurex | Privacy Policy | Disclaimer |